EU Antitrust Raids Target AstraZeneca

Law360, New York (December 3, 2010, 2:06 PM EST) -- European antitrust regulators have raided the offices of AstraZeneca PLC, citing suspicions that the pharmaceutical company colluded with other drugmakers to keep generic versions of a drug off the shelves.

U.K.-based AstraZeneca told Law360 on Friday that the European Commission carried out unannounced inspections of a “small number” of its European offices on Nov. 30 related to its multibillion-dollar heartburn and ulcer treatment drug Nexium.

Switzerland-based Nycomed US Inc., which produces a similar drug called Pantozol, also confirmed that regulators had raided two of its offices...
To view the full article, register now.